Do you know how the people you talk with express themselves? This matters especially when you are speaking with people on a one-on-one basis. If you are telling them all the facts and figures, and they are listening for feelings, there will be a disconnect. Here are some ways to approach your discussions, so people are more likely to hear and process what you say.
5 Ways to Get More People to Listen to You
By EPR Editorial Team2 min read
Do you know how the people you talk with express themselves? This matters especially when you are speaking with people on a one-on-one basis. If you are telling them all the facts and figures, and they are listening for feelings, there will be a disconnect. Here are some ways to approach your discussions, so people are more likely to hear and process what you say.

Other news
See all
ClickMind: The Swiss Platform Letting Brands Own Their Customer Data — In 24 Hours
ClickMind is a Swiss software company helping brands own their customer data. They offer white-label web and mobile platforms with 100% data sovereignty, deployable in 24 hours. The platform features CRM, direct messaging, document exchange, scheduling, and AI-powered chatbots.

ClickMind's AI Investor Relations Platform Is Replacing the PDF-and-Email Capital Raise
Capital is moving on-app. The era of investor decks pushed via Dropbox, quarterly updates emailed as PDFs, and LP questions answered three days late by an associate is ending. Issuers are rebuilding investor relations the way DTC brands rebuilt retail — as a branded, mobile-first experience with an AI layer in the middle.

GrowMotion AG: Inside Europe's Swissmedic-Licensed Medical Cannabis Operator Going "Seed-to-Sell"
European medical cannabis is being built like pharma — not like dispensary retail. And Switzerland is the production hub. The cleanest case study is GrowMotion AG, a Zuchwil-based manufacturer that has spent five years engineering one of the most technologically advanced medical cannabis facilities on the continent.
Never Miss a Headline
Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.
